Home Tags ZW49

Tag: ZW49

Featured Image: London Tower Bridge. Photo Courtesy: 2018 Fotolia

Zymeworks, Regeneron, Boehringer Ingelheim Pharma and Many Others are Betting on...

Antibody-Drug -Conjugates (ADCs) have the potential to reduce off-target toxicities in patients by limiting the exposure of normal tissues to the payload and broaden...
Featured Image - San Diego, CA at night. Courtesy 2019 Fotolia

Zymeworks Wins Best ADC Platform Technology Award for ZymeLink

Zymeworks, a clinical-stage biopharmaceutical company developing multifunctional biotherapeutics including bispecific antibodies and bispecific antibody-drug conjugates across a wide range of therapeutic indications, has won...